- Presentations
- 11
- Markets
- 1
Uptravi is a brand of Selexipag marketed by Actelion Pharmaceuticals, with 11 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Selexipag
- Brand owner
- Actelion Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1800 mcg/10 mL powder for injection, 100 mcg tablet, 1000 mcg tablet, 1200 mcg tablet, 1400 mcg tablet, 150 mcg tablet, 1600 mcg tablet, 200 mcg tablet, 400 mcg tablet, 600 mcg tablet, 800 mcg tablet
All presentations
Equivalent brands
Other brands of Selexipag.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Uptravi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.